|Back to main|
U.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to actively trade in Tuesday's session are Hillshire Brands Co. (HSH), InterDigital Inc. (IDCC) and Krispy Kreme Doughnuts Inc. (KKD).
G-III Apparel Group Ltd. (GIII) said its fiscal first-quarter earnings increased 15% as the company reported a notable jump in sales. The licensed apparel maker's results outpaced its own expectations, and it provided a rosier outlook for the current quarter compared with analysts' estimates while also boosting its view for the year. Shares rose 5.1% to $ 79.77 premarket.
Guidewire Software Inc.'s (GWRE) fiscal third-quarter loss narrowed, even as the software vendor reported an uptick in operating expenses that offset revenue growth. Shares edged up 1.6% to $37.50 premarket.
Hillshire on Tuesday said it would hold separate talks with Pilgrim's Pride Corp. (PPC) and Tyson Foods Inc. (TSN), who have offered to buy the maker of Jimmy Dean sausage and Sara Lee desserts. Pilgrim's Pride had raised its bid for Hillshire to $55 a share, topping Tyson's $50 a share offer. Hillshire's shares jumped 8.8% to $58.30 premarket.
InterDigital said it has entered into a patent license agreement with Samsung Electronics Co., which resolves all pending litigation between the two companies. Shares rose 8.7% to $40.65 premarket.
Krispy Kreme said fiscal first-quarter profit rose 20%, but severe weather hurt its results and the doughnut chain lowered its earnings guidance for the year. Shares dropped 11% to $17 premarket.
Quiksilver Inc. (ZQK) said its fiscal second-quarter loss widened as the sport outfitter's sales declined across its brands. Shares dropped 41% to $3.42 premarket.
Skyworks Solutions Inc. (SWKS) boosted its fiscal third-quarter outlook as the wireless-chip supplier said it is benefiting from the growth of connecting everyday objects to the Internet, known as the Internet of Things. Shares rose 4.5% to $45.02 premarket.
Acadia Healthcare Co. Inc. (ACHC) agreed to acquire U.K.-based independent behavioral-health services firm Partnerships in Care for roughly $660 million, providing a foothold in Britain.
AT&T Inc. (T) again raised its revenue guidance for the year, pointing to strong wireless trends in its second quarter. The telecommunications giant said it expects to report that it added more than 800,000 customers who signed long-term service contracts in the period, up sharply from 551,000 a year earlier.
Li & Fung will distribute some of Coty Inc.'s (COTY) key brands in China, including adidas, Rimmel and Playboy, as part of an agreement between the two companies. The move is part of Coty's efforts to reorganize its business in China and focus on growing its business in the world's second largest economy, the company said in a statement Tuesday.
Starboard Value LP, a New York investment adviser that has a roughly 6% stake in Darden Restaurants Inc. (DRI), has formally withdrawn its request for a special meeting of the board, but the group remains steadfast in replacing the restaurant chain's board of directors over the sale of the Red Lobster chain.
Dollar General Corp. (DG) said its fiscal first-quarter profit edged up 1.1% as the discount retailer recorded higher overall sales, though sales at existing stores missed the company's expectations.
Equipment-finance company Element Financial Corp. (EFN.T) has agreed to buy PHH Arval, the North American fleet- management unit of PHH Corp. (PHH), for about $1.4 billion.
HealthSouth Corp. (HLS) said it expects to exceed its earnings projections after it increased its ownership interest in Fairlawn Rehabilitation Hospital, in Worcester, Mass.
J.M. Smucker Co. (SJM) said it raised the prices on most of its coffee products by an average of 9% to reflect higher green coffee costs. The price increases primarily affect Folgers and Dunkin Donuts brand products and exclude products made for single-serve coffee machines.
Norwegian vaccine company Vaccibody and Phibro Animal Health Corp. (PAHC) have signed an exclusive license agreement for Phibro to use Vaccibody's technology platform in developing vaccines for the poultry market.
Teva Pharmaceutical Industries Ltd. (TEVA) has agreed to acquire migraine treatment-focused biotechnology company Labrys Biologics Inc. in a deal worth up to $825 million, as the drug maker looks to broaden its pain care offerings.
Write to Maria Armental at firstname.lastname@example.org
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires 06-03-140911ET Copyright (c) 2014 Dow Jones & Company, Inc.